Is SuperHealthy Rx legit?
A real business with a real prescription requirement. The question worth asking is what it dispenses and what it bills — $135 a month.
Updated 2026-10-04
SuperHealthy Rx operates legitimately: a licensed clinician reviews your intake before anything ships. Whether it is the right place to start a first course is a separate question.
"Legit" tends to mean two different things when people search it. One is "will I be scammed" — and on that, SuperHealthy Rx behaves like a legitimate business. The other is "is what I am being sold what I think it is", and that is the question worth more of your time.
Legitimate is not the same as suitable
A programme can be entirely above board and still be wrong for someone starting out — if support is thin when a dose goes badly, or if leaving means forfeiting a prepaid block. Our check covers legitimacy; the beginner question is answered on our rankings instead.
What we verified
- Compounded semaglutide from $85/month and tirzepatide from $135/month advertised.
All checked 2026-10-04 from published sources.
The five-point check
- Requires a prescription and a clinician review. Yes — SuperHealthy Rx routes intake through a licensed clinician before anything ships. Any seller that does not is the single clearest warning sign in this market.
- Names its compounding pharmacy. Not publicly. Ask before you order, and ask whether it is a 503A pharmacy or a registered 503B outsourcing facility.
- States what happens on cancellation. Less clearly than we would like. Check the terms before prepaying a multi-month plan.
Worth knowing. What "compounded" means here. A compounding pharmacy prepares the medication against an individual prescription. It is legal and long-established, but the preparation itself is not FDA-approved. Since the shortages resolved the rules have narrowed considerably — see is compounded still legal.
Where it falls short
- Compounded medication is not FDA-approved
- Service, pharmacy fulfillment and outcomes have not been independently tested
Red flags we did not find
- No prescription requirement — not the case here.
- Medication sold as "research chemicals" or "not for human consumption" — not the case here.
- Prices far below every other seller, which usually signals an unlicensed source.
- No way to contact a clinician after purchase.
- No named clinical leadership anywhere on the site.
The full checklist, and what to do if a seller fails it, is in how to spot a bad GLP-1 seller.
Our verdict
SuperHealthy Rx is legitimate in the sense most people mean. Whether it is *right* for you is a separate question, and it comes down to the $135 a month and compounded medication is not FDA-approved Our full assessment is in the SuperHealthy Rx tirzepatide review.
How it compares
| Programme | Per month | Dose-price | Our score |
|---|---|---|---|
| Coreage Rx Best overall on true monthly cost | $199 | Flat | 4.5 |
| SuperHealthy Rx Public offer; not independently scored | $135 | Varies | Not scored |
| Likeness Rx Public offer; not independently scored | $199 | Varies | Not scored |
| Trimi Lowest flat price with named pharmacies | $125 | Varies | 4.6 |
| PlexusDx Pharmacy transparency and genetic testing | $189 | Varies | 4.4 |
| Ozari Health Lowest advertised semaglutide price | $125 | Varies | 4.4 |
Read next
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- Is compounded medication still legal?
Yes, but much more narrowly than in 2024. What changed, and the five questions to ask before you start.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Best programmes if this is your first time
Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure